Press releases

Completed spin-off from 3M and began trading on April 1, 2024 Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS1 of...

Solventum (NYSE: SOLV) announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024. The earnings press release and...

Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board. Edwards will serve on Solventum's Audit and Talent committees, effective

Formerly 3M Health Care Business, Solventum (NYSE: SOLV) enables better, smarter, safer healthcare to improve lives ST. PAUL, Minn., April 1, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced...

- Leadership to highlight opportunity to unlock significant value creation over time - - Solventum to introduce full-year 2024 guidance - ST. PAUL, Minn., March 19, 2024 /PRNewswire/ -- Solventum...

Record date set for March 18, 2024 and distribution date set for April 1, 2024 ST. PAUL, Minn., March 8, 2024 /PRNewswire/ -- 3M (NYSE: MMM) today announced that its Board of Directors has...

3M (NYSE: MMM) today announced the filing of a Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) for the planned spin-off of its Health Care business as the...

3M (NYSE: MMM) today announced Solventum will be the name of the planned, independent health care company following its spin-off. Solventum originates from two words: "solving" and "momentum."...

3M (NYSE: MMM) today announced two leadership changes. In conjunction with the planned spin-off of the Health Care Business, we are announcing the departure of Jeff Lavers, group president, Health...

Wayde McMillan will join 3M’s Health Care Business Group to serve as chief financial officer effective Nov. 1. McMillan joins 3M from Insulet, an innovative medical device company improving the...